DRUG
NASDAQ · Biotechnology
Bright Minds Biosciences Inc
$80.00
+2.65 (+3.43%)
Open$77.83
Previous Close$77.35
Day High$80.10
Day Low$77.25
52W High$170.00
52W Low$50.50
Volume—
Avg Volume750
Market Cap1.11B
P/E Ratio—
EPS$-3.40
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
-66.3% upside
Current
$80.00
$80.00
Target
$26.95
$26.95
$16.82
$26.95 avg
$32.06
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 177.09M | 163.76M | 147.32M |
| Net Income | 34.74M | 43.56M | 40.99M |
| Profit Margin | 19.6% | 26.6% | 27.8% |
| EBITDA | 73.10M | 70.32M | 54.60M |
| Free Cash Flow | 20.82M | 31.20M | 18.21M |
| Rev Growth | -5.5% | +4.9% | +20.1% |
| Debt/Equity | 0.67 | 0.83 | 0.74 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |